David Bharucha's most recent trade in Milestone Pharmaceuticals Inc was a trade of 53,333 Series B Common Warrants (right to buy) done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 53,333 | 53,333 | - | - | Series B Common Warrants (right to buy) | |
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 53,333 | 63,333 (0%) | 0% | - | Common Shares | |
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 53,333 | 53,333 | - | - | Series A Common Warrants (right to buy) | |
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 120,600 | 120,600 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 80,400 | 80,400 | - | - | Restricted Stock Unit | |
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 185,000 | 185,000 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.69 per share. | 01 Dec 2022 | 7,000 | 10,000 (0%) | 0% | 4.7 | 32,830 | Common Shares |
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 01 Dec 2022 | 3,000 | 3,000 (0%) | 0% | 4.9 | 14,580 | Common Shares |
| Milestone Pharmaceuticals Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 330,000 | 330,000 | - | - | Employee Stock Option (right to buy) |